Predictors of Carotid Thickness and Plaque Progression During a Decade: The Multi-Ethnic Study of Atherosclerosis
-
2014/11/01
Details
-
Personal Author:Astor BC ; Gassett A ; Gepner AD ; Kaufman JD ; Korcarz CE ; Kronmal RA ; Liu KJ ; Sheppard L ; Stein JH ; Tattersall MC
-
Description:Background and Purpose: Carotid artery intima-media thickness (IMT) and plaque are noninvasive markers of subclinical arterial injury that predict incident cardiovascular disease. We evaluated predictors of longitudinal changes in IMT and new plaque during a decade in a longitudinal multiethnic cohort. Methods: Carotid IMT and plaque were evaluated in Multi-Ethnic Study of Atherosclerosis (MESA) participants at exams 1 and 5, a mean (standard deviation) of 9.4 (0.5) years later. Far wall carotid IMT was measured in both common and internal carotid arteries. A plaque score was calculated from all carotid segments. Mixed-effects longitudinal and multivariate regression models evaluated associations of baseline risk factors and time-updated medication use with IMT progression and plaque formation. Results: The 3441 MESA participants were aged 60.3 (9.4) years (53% women; 26% blacks, 22% Hispanic, 13% Chinese); 1620 (47%) had carotid plaque. Mean common carotid artery IMT progression was 11.8 (12.8) um/year, and 1923 (56%) subjects developed new plaque. IMT progressed more slowly in Chinese (B=-2.89; P=0.001) and Hispanic participants (B=-1.81; P=0.02), and with higher baseline high-density lipoprotein cholesterol (per 5 mg/dL; B=-0.22; P=0.03), antihypertensive use (B=-2.06; P=0.0004), and time on antihypertensive medications (years; B=-0.29; P<0.0001). Traditional risk factors were associated with new plaque formation, with strong associations for cigarette use (odds ratio, 2.31; P<0.0001) and protection by black ethnicity (odds ratio, 0.68; P<0.0001). Conclusions: In a large, multiethnic cohort with a decade of follow-up, ethnicity was a strong, independent predictor of carotid IMT and plaque progression. Antihypertensive medication use was associated with less subclinical disease progression. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0039-2499
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:45
-
Issue:11
-
NIOSHTIC Number:nn:20054802
-
Citation:Stroke 2014 Nov; 45(11):3257-3262
-
Contact Point Address:James H. Stein, MD, University of Wisconsin School of Medicine and Public Health, 600 Highland Ave, Room H4/520 CSC (MC 3248), Madison, WI 53792
-
Email:jhs@medicine.wisc.edu
-
Federal Fiscal Year:2015
-
Performing Organization:University of Washington
-
Peer Reviewed:True
-
Start Date:20050701
-
Source Full Name:Stroke
-
End Date:20250630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:a69209b5a85d77936dc6345c472fe613299efce36360f1ddfe1e56faec6c8af61c9f8948d96e11110715104847ad26f1aa5d33a9a78c0368dd4efd55f5bb8d3b
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like